Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure.

• Authors: Joost C Beusekamp, Jasper Tromp, Eva M Boorsma, Hiddo J L Heerspink, Kevin Damman, Adriaan A Voors, Peter van der Meer
• Journal: European journal of heart failure (Eur J Heart Fail) Vol. 23 Issue 6 Pg. 1049-1052 (06 2021) ISSN: 1879-0844 [Electronic] England
• PMID: 33899306 (Publication Type: Letter)

Chemical References

• Benzhydryl Compounds
• Glucosides
• SLC5A2 protein, human
• Sodium-Glucose Transporter 2
• Sodium-Glucose Transporter 2 Inhibitors
• Sodium
• empagliflozin
• Glucose
• Potassium

Topics

• Benzhydryl Compounds
• Diabetes Mellitus, Type 2 (drug therapy)
• Glucose
• Glucosides
• Heart Failure (drug therapy)
• Humans
• Potassium
• Sodium
• Sodium-Glucose Transporter 2
• Sodium-Glucose Transporter 2 Inhibitors (therapeutic use)